Medicare Enrolled
Dr. Michael McCleod, DO
Medical Oncology · Fort Myers, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McCleod from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McCleod?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McCleod
Dr. Michael McCleod is a medical oncology specialist in Fort Myers, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. McCleod performed 118,427 Medicare services across 3,891 unique beneficiaries.
Between the years covered by Open Payments, Dr. McCleod received a total of $31,426 from 94 pharmaceutical and/or device companies across 1104 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McCleod is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 20% volume in FL
$31,426 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Osteopathic Physician | 5832 | Clear | March 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗118,427
Medicare services
Top 20% in FL for medical oncology
3,891
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,921 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 21,400 | $39 | $137 |
| Filgrastim injection (Zarxio) for white blood cells An injection of the biosimilar medication filgrastim-sndz (Zarxio) with a dosage of 1 microgram. |
18,000 | $0 | $2 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
17,340 | $0 | $4 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
16,100 | $6 | $23 |
| Denosumab injection (Prolia/Xgeva) | 11,220 | $18 | $51 |
| Anti-nausea injection (aprepitant) | 7,670 | $1 | $5 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
7,568 | $36 | $108 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
5,200 | $0 | $5 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
2,294 | $8 | $29 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,016 | $8 | $9 |
| Iron infusion (Monoferric) | 1,400 | $16 | $57 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,159 | $0 | $3 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
942 | $65 | $239 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
768 | $11 | $69 |
| Anti-nausea injection (Aloxi/palonosetron) | 661 | $1 | $28 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
579 | $100 | $339 |
| Injection, leucovorin calcium, per 50 mg | 522 | $3 | $12 |
| Anti-nausea injection (ondansetron/Zofran) | 436 | $0 | $9 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
425 | $12 | $61 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
417 | $96 | $378 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
318 | $2 | $7 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
233 | $48 | $189 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
217 | $1 | $3 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
198 | $22 | $79 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
172 | $16 | $56 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
137 | $1 | $6 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
123 | $22 | $84 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
106 | $10 | $42 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
91 | $16 | $59 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
78 | $2 | $7 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
72 | $25 | $89 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
69 | $49 | $178 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
69 | $6 | $69 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
59 | $57 | $206 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 53 | $129 | $562 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
50 | $24 | $156 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
50 | $74 | $298 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
40 | $140 | $637 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
38 | $136 | $453 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
30 | $29 | $156 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
29 | $1 | $7 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
27 | $2 | $8 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
18 | $3 | $11 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
17 | $66 | $277 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
16 | $5 | $20 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
23.2% high complexity
71.5% medium
5.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$31,426
Total received (2018-2024)
Avg $4,489/year across 7 years
Top 18% in FL for medical oncology
94
Companies
1,104
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,654 (75.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,772 (24.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,900
2023
$3,416
2022
$3,529
2021
$2,905
2020
$2,078
2019
$9,589
2018
$6,009
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
F. Hoffmann-La Roche AG
$7,701
Novartis Pharmaceuticals Corporation
$1,740
E.R. Squibb & Sons, L.L.C.
$1,576
AstraZeneca Pharmaceuticals LP
$1,402
Incyte Corporation
$1,140
Janssen Biotech, Inc.
$1,001
PFIZER INC.
$879
GENZYME CORPORATION
$871
Genentech USA, Inc.
$869
Celgene Corporation
$857
Amgen Inc.
$819
Seagen Inc.
$778
Merck Sharp & Dohme Corporation
$709
Lilly USA, LLC
$654
Merck Sharp & Dohme LLC
$632
Exelixis Inc.
$570
Eisai Inc.
$490
BeiGene USA, Inc.
$452
Daiichi Sankyo Inc.
$434
JAZZ PHARMACEUTICALS INC.
$431
Clovis Oncology, Inc.
$341
GlaxoSmithKline, LLC.
$340
Foundation Medicine, Inc.
$330
Dova Pharmaceuticals
$313
Rigel Pharmaceuticals, Inc.
$304
EISAI INC.
$300
NanoString Technologies, Inc.
$262
Gilead Sciences, Inc.
$261
Bayer HealthCare Pharmaceuticals Inc.
$220
EMD Serono, Inc.
$215
Epizyme, Inc.,
$212
Bayer Healthcare Pharmaceuticals Inc.
$202
Astellas Pharma US Inc
$199
ADC Therapeutics America, Inc.
$194
TAIHO ONCOLOGY, INC.
$185
Janssen Scientific Affairs, LLC
$184
Boehringer Ingelheim Pharmaceuticals, Inc.
$181
Puma Biotechnology, Inc.
$180
Kite Pharma, Inc.
$176
PharmaEssentia USA Corporation
$164
CTI BioPharma Corp.
$164
Takeda Pharmaceuticals U.S.A., Inc.
$138
Dendreon Pharmaceuticals LLC
$128
Pharmacyclics LLC, An AbbVie Company
$126
BioMarin Pharmaceutical Inc.
$125
G1 Therapeutics, Inc.
$115
Alexion Pharmaceuticals, Inc.
$108
Veracyte, Inc.
$105
TerSera Therapeutics LLC
$97
Myovant Sciences Inc.
$97
Deciphera Pharmaceuticals Inc.
$84
CSL Behring
$83
Mirati Therapeutics, Inc.
$68
Taiho Oncology, Inc.
$68
Agios Pharmaceuticals, Inc.
$59
PUMA BIOTECHNOLOGY, INC.
$58
Seattle Genetics, Inc.
$56
MorphoSys, US Inc.
$54
Kyowa Kirin, Inc.
$54
Janssen Pharmaceuticals, Inc
$50
ARRAY BIOPHARMA INC
$47
AMAG Pharmaceuticals, Inc.
$44
Stemline Therapeutics Inc.
$43
EUSA Pharma (US) LLC
$43
SOBI, INC
$40
GE HEALTHCARE
$40
Acrotech Biopharma LLC
$34
Otsuka America Pharmaceutical, Inc.
$33
INSYS Therapeutics Inc
$30
Sumitomo Pharma America, Inc.
$29
SpringWorks Therapeutics, Inc.
$25
ABBVIE INC.
$25
Aurobindo Pharma USA, Inc.
$24
Jazz Pharmaceuticals Inc.
$24
Pharmacyclics LLC, an AbbVie Company
$23
Sysmex Inostics Inc
$23
TESARO, Inc.
$22
Acrotech Biopharma Inc.
$22
Spectrum Pharmaceuticals Inc.
$21
Secura Bio, Inc.
$20
AbbVie, Inc.
$20
Heron Therapeutics, Inc.
$19
Myriad Genetic Laboratories, Inc.
$19
AVEO Pharmaceuticals, Inc.
$18
Sobi, Inc
$17
Immunocore Limited
$16
Partner Therapeutics, Inc.
$16
BIOVERATIV THERAPEUTICS INC.
$14
Alnylam Pharmaceuticals Inc.
$14
Global Blood Therapeutics, Inc.
$13
Horizon Therapeutics plc
$12
Lexicon Pharmaceuticals, Inc.
$12
Helsinn Therapeutics (U.S.), Inc.
$11
Emmaus Medical, Inc.
$10
Top 3 companies account for 35.1% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALIMTA · ALUNBRIG · Abraxane · Alecensa · Aliqopa · Avastin · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · CINVANTI · COSELA · CYRAMZA · Cabometyx · Cinvanti · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELITEK · ELOCTATE · ELREXFIO · EMPLICITI · ENHERTU · ERLEADA · Endari · Enhertu · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · GAZYVA · GILOTRIF · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INREBIC · Idelvion · JADENU · JAKAFI · JAYPIRCA · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · KRYSTEXXA · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lonsurf · MARQIBO · MEKINIST · MONJUVI · MVASI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Nplate · Nubeqa · OCREVUS · OGSIVEO · OJJAARA · ONPATTRO · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Perjeta · Polivy · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETEVMO · ROCTAVIAN · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SPRYCEL · SUTENT · SYNDROS · Stivarga · Sustol · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XOSPATA · XTANDI · Xermelo · Xospata · Yescarta · ZEJULA · ZEPZELCA · ZEVALIN · ZOLADEX · ZYKADIA · ZYTIGA · Zevalin · Zoladex · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (75%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $27 per 100 Medicare services performed
Geographic Context
Medical oncologists within 10 mi
11
Per 100K population
1.4
County median income
$73,099
Nearest hospital
LEE MEMORIAL HOSPITAL
8.0 mi
8.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. McCleod is a mixed practice specialist, with above-average Medicare volume (top 20% in FL), with low-engagement industry engagement in the top 18% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. McCleod experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. McCleod performed 21,400 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McCleod receive payments from pharmaceutical companies?
Yes. Dr. McCleod received a total of $31,426 from 94 companies across 1,104 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McCleod's costs compare to other medical oncologists in Fort Myers?
Dr. McCleod's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McCleod) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Fort Myers
Browse medical oncologists in Fort Myers ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in FL
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in FL
Which FL medical oncologists receive the most from drug and device companies.
By company
F. Hoffmann-La Roche AG Payments to Doctors
See all physicians who received payments from F. Hoffmann-La Roche AG.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology